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Ultraviolet irradiation represents a well-established
treatment modality for in£ammatory skin diseases.
The aim of this study was to investigate the mechan-
isms of ultraviolet B radiation-induced keratinocyte
insensitivity towards interferon-c. Flow cytometric
analyses indicated that ultraviolet B radiation tempora-
rily inhibits the interferon-c-induced activation of pri-
mary keratinocyte and HaCaT cells as measured by
reduced intercellular adhesion molecule-1 (CD54) and
HLA-DR upregulation. Western blot experiments have
suggested that this is mediated by the ultraviolet B ra-
diation-induced inhibition of signal transduction and
transcription factor-1 phosphorylation. Neither inter-
leukin-10 neutralization nor interleukin-10 addition
had any e¡ect on the ultraviolet B radiation-induced in-
hibition of interferon-c induced intercellular adhesion
molecule-1 expression. Furthermore, the supernatant
from ultraviolet B-irradiated cells failed to inhibit the
interferon-c-induced CD54 and HLA-DR upregulation
in nonradiated HaCaT cells. Moreover, irradiated cells
from whom the supernatant was withdrawn 4 h after
irradiation still showed a diminished interferon-c-
induced response after 24 h. Thus, not soluble but intra-
cellular factors might be involved in the ultraviolet B
radiation-induced inhibition of interferon-c-induced
keratinocyte activation. Therefore, we analyzed the ex-
pression of members of suppressors of cytokine-signal-
ing (SOCS) molecules using real-time polymerase
chain reaction.We found a fast and strong upregulation
of SOCS1 and SOCS3 but not of SOCS2 after ultravio-
let B radiation. Similarly, ultraviolet B radiation in-
duced the expression of these particular SOCS
molecules in lesional psoriatic skin. As SOCS molecules
are known inhibitors of signal transduction and tran-
scription factor phosphorylation, which is essential for
interferon-c-induced intercellular adhesion molecule-1
and HLA-DR upregulation, this may explain the inter-
feron-c unresponsiveness after ultraviolet B radiation.
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K
eratinocyte activation is a typical hallmark of several
dermatoses, including psoriasis. Activated keratino-
cytes show enhanced proliferation and production
of cytokines and other mediators, as well as modi-
¢ed surface molecule expression. Enhanced expres-
sion of the intercellular adhesion molecule 1 (ICAM-1/CD54)
and the major histocompatibility complex molecule (HLA)-DR
are often used as markers of keratinocyte activation. The expres-
sion of these surface molecules, which are not present in resting
keratinocytes, are also considered to have pathophysiologic im-
portance. CD54 serves as a ligand for the leukocyte function-as-
sociated antigen-1, and ICAM1/leukocyte function-associated
antigen-1 binding appears to be the major pathway for the attach-
ment of lymphocytes and monocytes to keratinocyte (Krutmann
et al, 1990). It has also been shown that HLA-DR-expressing ker-
atinocytes can activate T cells (Strange et al, 1994). Taken together
de novo expression of ICAM-1 and HLA-DR on keratinocytes
seems to have an impact on the initiation and maintenance of
cutaneous in£ammatory and immune responses.
It is well established that the pro-in£ammatory cytokine inter-
feron (IFN)-g is a major activator of keratinocyte, which induces
HLA-DR and ICAM-1 expression in vitro (Caughman et al, 1990).
Remarkably, strong expression of all three molecules, IFN-g,
HLA-DR, and ICAM-1 has been described in lesional psoriatic
(Asadullah et al, 2001) and atopic skin (Leung and Soter, 2001)
suggesting the in vivo relevance of this ¢nding. Ultraviolet (UV)
irradiation represents a well-established modality for the treat-
ment of in£ammatory skin diseases. For example, UVB (280^
320 nm) is used to treat patients with psoriasis or atopic dermatitis
(Simon et al, 2000). Keratinocytes constitute an important
cellular target of UV radiation (UVR)-induced immunomodu-
lation (Krutmann and Elmets, 1988; Grewe et al, 1995). Several re-
ports clearly described that UV light is a potent regulator of
keratinocyte basal and IFN-g-induced ICAM-1 expression and
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suggest that this may contribute to its mode of action (Krutmann
et al, 1990; Norris et al, 1990; Clingen et al, 2001). Remarkably, the
e¡ects of UVR on CD54 expression are biphasic, producing in-
hibition at 24 h and induction of this molecule at 48 to 96 h. It
was suggested that, whereas the early inhibition of ICAM-1 con-
tributes to the therapeutic e¡ects of UVR in in£ammatory der-
matoses, the late induction of ICAM-1 might represent an
important step in the induction of photosensitive diseases such
as lupus erythematosus (Norris et al, 1990 Krutmann et al, 1992;
Krutmann and Grewe, 1995; Kuhn et al, 2002).
The underlying mechanisms for the UV-mediated modulation
of IFN-g-induced keratinocyte activation are only partly under-
stood. Clinical e⁄cacy of UV phototherapy was found to be as-
sociated with signi¢cant downregulation of in-situ expression of
IFN-g in skin (Krutmann et al, 1992; Grewe et al, 1994, 1995), and
UVR has been shown to inhibit the IFN-g production of T cells
in vivo (Simon et al, 1994). Thus, loss of keratinocyte activation,
including CD54 induction may simply be the consequence of
downregulated IFN-g production. UVR, however, can e¡ec-
tively reduce the state of keratinocyte activation even during con-
tinuous IFN-g exposition, suggesting the existence of other
mechanisms. The involvement of both DNA damage (Krutmann
and Grewe, 1995) and IFN-g unresponsiveness due to inhibition
of signal transduction molecules has been suggested. Grawe and
coworkers demonstrated that in human antigen-presenting cells
the inhibition of ICAM-1 expression by UVBR is achieved via
the generation of cyclobutane pyrimidine dimers (Grewe et al,
2000). Aragane and coworkers demonstrated that UVR inhibits
the phosphorylation of the signal transduction and transcription
factor (STAT)-1, which is essential for mediating signals of several
cytokines, including IFN-g. They suspected that that activation
of a phosphatase might be important for this phenomenon
(Aragane et al, 1997).
The aim of this investigation was to elucidate further the me-
chanisms of the inhibitory action of UVR on IFN-g-induced
keratinocyte activation. It has been suggested that UV-induced
expression of the immunosuppressive cytokine IL-10 (Grewe
et al, 1995) and release of further soluble molecules (Kim et al,
1990; Luger et al, 1999) largely contribute to the local and systemic
immunosuppressive and anti-in£ammatory e¡ects of UVR.
Therefore, we ¢rst analyzed their impact on the unresponsiveness
of keratinocyte regarding IFN-g. As no evidence for a major role
of such secreted molecules was found, we then analyzed the ef-
fects of UVR on the expression of a recently described family of
intracellular proteins acting as negative inhibitors of cytokine sig-
naling.We have demonstrated here for the ¢rst time that UVR is
able to induce the expression of suppressors of cytokine signaling
(SOCS)-1 and 3, molecules known to be potent inhibitors of
STAT.
MATERIALS AND METHODS
Cell cultures Human epidermal cell suspensions were obtained from
normal donors undergoing breast or foreskin surgery. All subjects who
gave material (skin biopsies or blood) to our scienti¢c work have given
their informed consent. After displacing fat tissue and vascular vessels, the
epidermis was stored in dispase (1.2 mg per mL) solution for 24 h at 41C.
Separation of dermis and epidermis was followed by seeding the epidermal
cells at 6105 per mL in six-well Tissue Culture Plates (Becton Dickinson,
San Jose, California) in serum-free keratinocyte growth medium (Cell-
Lining, Berlin, Germany). For the performed experiments, cells were
grown as a monolayer to subcon£uency 7 to 9 d after seeding.
In addition, the human keratinocyte cell line HaCaT, initially derived
from an adult donor, kindly provided by N.E. Fusenig (Boukamp et al,
1988) was grown in Dulbecco’s modi¢ed Eagle’s medium (Invitrogen
Corporation, Paisley, UK) with 4.5 g per liter glucose supplemented with
1% L-glutamine (Biochrome, Berlin, Germany), antibiotics (1 U per mL
penicillin; 10 mg streptomycin per mL; Invitrogen, Karlsruhe, Germany),
and 5% heat-inactivated fetal bovine serum (Invitrogen). All cells
were cultured in a humidi¢ed incubator at 371C with 5% CO2/95%
air. Keratinocytes were passaged by dissociating the monolayer with
ethylenediamine tetraacetic acid (0.01%; Invitrogen Corporation), fol-
lowed by trypsin (0.025%; Invitrogen Corporation). Cells were grown for the
experiment as a monolayer to subcon£uency 48 h after seeding.The HaCaTcell
line shares some similarities with psoriatic keratinocytes, such as keratin
17 expression (Bonnekoh et al, 1995).
Peripheral blood mononuclear cells (PBMC) were prepared from the
heparinized blood of healthy donors by centrifugation with Ficoll-
Hypaque density gradient (on Jouan MR 22, Saint Herblain, France).
PBMC were cultured at 1106 per mL (in six-well Tissue Culture Plates;
Becton Dickinson) in RPMI medium supplemented with 1% L-glutamine
(Biochrome), antibiotics (1 U per mL penicillin; 10 mg streptomycin per
mL; Invitrogen), and 10% fetal bovine serum (Invitrogen) for 2 h before
undergoing UV irradiation and stimulation.
UV irradiation and stimulation assays
UVB irradiation UVB exposures were performed using a £uorescence tube
lamp (type TL-12 [40 W], Philips lighting B.V., Hamburg, Germany). The
irradiance of the lamp measured with a spectral resolution of 1 nm by using
a temperature-stabilized double monochromator spectroradiometer (type
OL 754, Optronic Inc., Orlando, Florida) and a cosine corrected Ulbricht
sphere as optical head was 3.26 W per m2 in the UVB range (280^315 nm)
and 0.03 W per m2 for wavelengths below 250 nm (UVC). The dose re-
ceived by the keratinocyte and PBMC cultures during an exposure time
of 46 s each was 150 J per m2 tissue culture. Thereafter, cells were medium
supplemented and incubated at 371C with 5% CO2.
Stimulation with IFN-g Semicon£uent cultures of keratinocyte or PBMC
were stimulated with recombinant human IFN-g (R&D Systems,Wiesba-
den, Germany) at a concentration of 10 ng per mL, 4 h or 24 h after UV
irradiation for 24 h.
IL-10 neutralization Keratinocytes were incubated in the presence of a neu-
tralizing anti-IL-10 monoclonal antibody (CB-RS-1; Sabat et al, 1996) at a
concentration of 10 mg per mL immediately after UV irradiation for 28 h.
Stimulation with IL-10 Keratinocytes were incubated in the presence of re-
combinant human IL-10 (SCH 52000; kindly provided by Essex Pharma,
Munich, Germany/Schering Plough Research Institute, Kenilworth,
New Jersey) at a concentration of 10 ng per mL, 4 h after UV irradiation
for 24 h.
Stimulation with supernatant obtained from irradiated cells The supernatant of
UV-radiated keratinocyte was collected and replaced by that from nonra-
diated cells 4 h and 24 h after UV irradiation.
To prove the bioactivity of the test compounds (IL-10 and anti-IL-10
antibody) we determined both inhibitory and stimulatory e¡ects of this
cytokine. In two independent experiments IL-10 strongly induced CD16
and reduced HLA-DR expression on monocytes as characteristic e¡ects of
IL-10 activity (Moore et al, 2001). These e¡ects were completely blocked by
the anti-IL-10 antibody, whereas a control antibody did not have any in£u-
ence (data not shown).
Fluorescence-activated cell sorter analyses of CD54 and HLA-DR
expression To analyze surface molecule expression, cells were harvested
by trypsination and stained with £uorescein isothiocyanate-conjugated
anti-CD54 (8.4A6, Biosource International, Nivelles, Belgium) and anti-
HLA-DR (L243, Becton Dickinson) antibodies. In control samples,
staining was performed using mouse IgG1 Isotype control (11711.11, R&D
Systems). Flow cytometric analysis was performed using FACScan
equipment and CellQuest software (both Becton Dickinson). The Geo
Mean was used for data analysis.
Western blot analysis for detection of activated stat-1 Keratinocytes
were cultured for 48 h. UVB radiation (UVBR) was performed at
150 J per cm2, followed by IFN-g stimulation with recombinant human
IFN-g (R&D Systems) 4 h after irradiation. For detection of acti-
vated (phosphorylated) STAT-1 (pSTAT), cells were washed 15 min after
treatment with phosphate-bu¡ered saline, ethylenediamine tetraacetic acid
(0.01%, Invitrogen), followed by trypsin (0.025%; Invitrogen). Protein
extracts were prepared by solubilizing cell pellets in cell lysis bu¡er
containing: 1 mM HEPES; 0.5% nonidet P40; 0.5 mM MgCl2; 0.1%
b-mercaptoethanol; 0.1% sodium dodecyl sulfate; 1 mg aprotinin per mL;
3 mg pepstatin per mL; and 0.2 mM phenylmethylsulfonyl £uoride. Cells
were resuspended in bu¡er, stored on ice for 30 min and centrifuged at
20,000 g for another 30 min. Cell pellets thus obtained were stored at ^
701C. Protein assays were performed using the BCA Protein Assay Kit
(Perbio, Rockford IL).
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Samples were fractionated in 7.5% sodium dodecyl sulfate/polyacryl-
amide gel electrophoresis and blotted on to nitrocellulose membranes (Hybond-
enhanced chemiluminescence, Amersham Pharmacia Biotech Bucks, UK).
Membranes were then blocked and probed with primary antibodies
diluted in phosphate-bu¡ered saline containing 5% nonfat dried milk.
Western blot analysis was performed using: anti-STAT-1 (E-23, G311,
Santa Cruz Biotechnology, Santa Cruz, California), anti-phosphotyrosine
STAT-1 (A-2, J120, Santa Cruz Biotechnology). This particular anti-STAT-
1 antibody recognizes both STAT-1a and STAT-1b. Filters were properly
developed with anti-murine or anti-rabbit immunoglobulin antibodies
conjugated to horseradish peroxidase using the ECL-plus detection
system (Amersham Pharmacia Biotech), followed by autoradiography.
Skin biopsies Serial biopsies (6 mm punch biopsies) from the same
psoriatic plaque were obtained from two adult, male patients with
moderate or severe chronic plaque psoriasis undergoing UVB therapy.
The ¢rst biopsy was obtained before therapy, whereas the second biopsy
was obtained 24 h after the third application of UVB (0.9 J per cm2). The
collection of this patient material was approved by the Institutional
Review Board of the Medical Faculty, and informed consent was
obtained from all patients. The skin biopsies were immediately snap
frozen in guanidinium isothiocyanate solution and stored at ^701C.
Gene expression analysis for SOCS expression SOCS mRNA
expression was determined in HaCaT cells and in homogenized skin
biopsies by real-time polymerase chain reaction (Asadullah et al, 2001).
HaCaT cells were harvested by trypsination after 0.5, 1, 4, and 24 h,
respectively, and washed with phosphate-bu¡ered saline once. The cell
pellets were resuspended in lysis-bu¡er (Invitek, Berlin, Germany) and
stored at ^701C. Total RNA was prepared using Invisorb RNA Kit II
(Invitek) according to the supplier’s speci¢cations. Reverse transcription of
mRNA was performed as follows: 0.05 mg per mL total RNA of each
sample were incubated in the presence of 5 ng per mL oligo-d(T)12^18
primers (Gibco BRL, Eggenstein, Germany) at 751C for 5 min and
cooled on ice afterwards. After the addition of Strand bu¡er (Gibco
BRL), 1 unit per mL of RNasin ribonuclease inhibitor (Promega,
Mannheim, Germany), 10 mM dithiothreitol (Gibco BRL), 250 mM of
deoxyadenosine triphosphate, deoxythymidine triphosphate, deoxycy-
tidine triphosphate, and deoxyguanosine triphosphate (Pharmacia
Biotech, Uppsala, Sweden), and 5 units per mL Moloney murine leukemia
virus reverse transcriptase (Gibco BRL), a reaction took place at 421C for
60 min and was stopped afterwards by heating to 951C for 5 min. The
samples were then analyzed in triplicate assays by real-time polymerase
chain reaction using TaqMan universal master mix (Applied Biosystems,
Weiterstadt, Germany) in the ABI Prism 7700 Sequence Detector System
Applied Biosystems, Weiterstadt, Germany. The sequences and concen-
trations of primers and 6-carboxy-£uorescein/6-carboxy-tetramethyl-
rhodamin double-labeled samples are shown in Table I. Thermal
con-ditions in each of the 40 cycles were 15 s at 951C and 1 min at 601C.
Statistical analysis Data are presented as mean 7 SEM. Statistical
analysis was performed with the SPSS software for windows using the
Student’s t test for paired samples to compare values for CD54 and
HLA-DR expression on keratinocyte and PBMC. Di¡erences were con-
sidered signi¢cant at po0.05.
RESULTS
UVBR inhibits the IFN-c-induced ICAM-1 and HLA-
DR expression CD54 expression was determined after 24 h
culture with or without IFN-g and an additional 4 h pre-
incubation after UVBR. Whereas IFN-g induced a strong
upregulation (about 4^5-fold) of CD54 in keratinocytes that
were not exposed to UVB before, this was signi¢cantly lower in
UVB exposed cells (about 2-fold). Thus, both UV-radiated fresh
cells and HaCaT cells showed a signi¢cantly diminished CD54
expression compared with their nonradiated controls (Fig 1B
and C, po0.05 and po0.001, respectively). Similarly, UV
preradiation inhibited the IFN-g-induced CD54 expression on
monocytes (Fig 1A). Similar e¡ects as for CD54 were observed
concerning HLA-DR expression. HLA-DR expression was
strongly upregulated in IFN-g-stimulated and nonradiated cells
but not in IFN-g-stimulated and preradiated HaCaT cells (Fig
1E). The same was the case for monocytes where IFN-g strongly
enhanced the HLA-DR expression in nonradiated cells but only
to a much lower extent in preradiated cells (Fig 1D). Thus, the
data indicate that UVR potently inhibits IFN-g-induced
keratinocyte and monocyte activation, which is in line with
previously published work (Krutmann et al, 1990; Norris et al,
1990; Grewe et al, 2000; Clingen et al, 2001).
UVBR-mediated inhibition of IFN-c-induced keratinocyte
and monocyte activation is transient The e¡ects of UVR
on CD54 induction in keratinocytes have been described as
biphasic, with inhibition at 24 h and induction at 48 to 96 h
(Norris et al, 1990; Krutmann et al, 1992; Krutmann and Grewe,
1995). Therefore, we next investigated the e¡ects of UVR on
IFN-g-induced ICAM-1 and HLA-DR expression on keratino-
cytes and monocytes after longer incubation time (addition of
IFN-g 24 h after UVR). Remarkably an upregulation of CD54
expression was observed on HaCaT cells (Fig 2). Thus, although
a general biphasic course with early suppression and late
enhancement could not be demonstrated here, the inhibitory
e¡ect of UVR on IFN-g-induced keratinocyte and monocyte
cell activation is clearly temporary.
UVBR inhibits the IFN-c-induced keratinocyte STAT-1
phosphorylation In order to determine whether UVB has an
e¡ect on IFN-g-induced signal transduction we investigated the
e¡ects of UVBR on the level of pSTAT-1 expression.Whole-cell
extracts were analyzed by western blot using a monoclonal
antibody speci¢cally recognizing pSTAT-1. pSTAT-1was weakly
detectable in nonstimulated cells. In contrast, strong expression
Table I. Sequences of primers and 6-carboxy-£uorescein (FAM)/6-carboxy-tetramethyl-rhodamine (TAMRA)
double-labeled probes
Gene oligonucleotide sequences Concentration (nM)
SOCS 1 50 -CCGCGACTACCTGAGCTCCTT-30 900
50 -AGTTAATGCTGCGTGCACGG-30 50
FAM-50 -TTCCAGATTTGACCGGCAGCGC-30 -TAMRA 200
SOCS 2 50 -AAACCGCTCTACACGTCAGCA-30 300
50 -AgATGGCACCGGTACATTTGTTA-30 300
FAM-50 -TCTCTGCAGCATCTCTGTAGGCTCACCAT-30 -TAMRA 200
SOCS 3 50 -CTTTCTGATCCGCGACAGCT-30 300
50 -TCACACTGGATGCGCAGGT-30 300
FAM-50 -CCAGCGCCACTTCTTCACGCTCAG-30 -TAMRA 200
HPRT-1 50 -GACTTTGCTTTCCTTGGTCAGG-30 300
50 -AGTCTGGCTTATATCCAACACTTCG-30 300
FAM-50 -TTTCACCAGCAAGCTTGCGACCTTGA-30 -TAMRA 200
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was found after IFN-g stimulation for 15 min. Remarkably,
preradiation with UVB at 150 J per cm2, followed by 15 min
IFN-g stimulation 4 h after irradiation strongly inhibited
pSTAT-1 formation, con¢rming recently published results
(Aragane et al, 1997) (Fig 3). We detected a double band of
pSTAT-1 because the particular antibody we used recognizes
both STAT-1a and STAT-1b. Thus, UVB potently inhibits IFN-
g-induced signal transduction, which explains the diminished
capability of this cytokine to stimulate keratinocytes after UVB
radiation.
UVBR-induced modulation of IFN-c caused keratinocyte
activation is independent from endogenous IL-10/soluble
mediators We then addressed the question whether the UVR-
induced inhibition of keratinocyte activation is mediated by a
soluble mediator. A primary susceptible candidate is IL-10, as it
Figure1. UVBR inhibits the IFN-c induced ICAM-1 and HLA-DR expression on keratinocytes and monocytes after 24 h. CD54 and HL-DR
expression was measured on monocytes (A,D), HaCaT cells (B,E) and fresh keratinocytes (CD54 only; C) 24 h after culture with or without IFN-g (10 ng
per mL) and additional previous 4 h preincubation following UVB radiation (150 J per cm2) by £ow cytometry. po0.05, po0.005. UVBRþ IFN-g
stimulation.
Figure 2. Twenty-four hour incubation after UVBR before IFN-c stimulation fails to inhibit keratinocyte and monocyte activation. Mono-
cytes (A,D), HaCaT cells (B,E), and fresh keratinocytes (C,F) were incubated after UVB radiation (150 J per m2) for 24 h and stimulated then with IFN-g
(10 ng per mL) or left without stimulation for another 24 h. CD54 and HLA-DR expression was determined thereafter by £uorescence-activated cell sorter
analyses as described in Materials and Methods. po0.05. UVBRþ IFN-g stimulation.
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is known to be induced by UVBR (Grewe et al, 1995), to inhibit
HLA-DR expression on monocytes (Asadullah et al, 1998), and to
suppress tyrosine phosphorylation of STAT-1 (Ito et al, 1999).
Therefore, a set of experiments was performed: keratinocytes
were incubated in the presence of a neutralizing anti-IL-10
monoclonal antibody (Fig 4A) or IL-10 (Fig 4B,C) just before
UVB radiation. Neither IL-10 neutralization nor IL-10 addition
had any e¡ect on the UVBR-induced inhibition of IFN-g-
induced CD54 expression (Fig 4). Bioactivity of the test
compounds (IL-10 and the neutralizing anti-IL-10 antibody) has
been proven (see Materials and Methods). All in all this fairly
excludes any role of IL-10 on the UVBR modulation of IFN-g-
mediated keratinocyte activation.
To determine if a soluble factor is involved at all, the
supernatant of UV-radiated keratinocytes was collected and
replaced by that from nonradiated cells after 4 h. Thereafter,
cells were stimulated with IFN-g for 24 h. The supernatant from
UV-radiated cells failed to induce suppression of CD54 (Fig 5A)
and HLA-DR (Fig 5B) in nonradiated HaCaT cells. Moreover,
the radiated cells from whom the supernatant was obtained
showed a diminished CD54 and HLA-DR expression, indisting-
uishable from that of UV-radiated ordinary keratinocyte cultures,
which remained in their supernatant for the whole period (Fig 5).
Thus, no soluble factor at all seems to be involved in the UVB-
induced inhibition of IFN-g-induced keratinocyte activation
suggesting that direct induction of an intracellular molecule
mediates this e¡ect.
UVR induces SOCS1 and SOCS3 expression in keratinocytes
So far, the experiments have suggested that an intracellular
molecule must be responsible for the UV-induced modulation
of IFN-g-induced keratinocyte activation. Recently, a new
family of intracellular proteins has been identi¢ed as potent
inhibitors of cytokine signaling. Particularly interesting candi-
dates from this family are SOCS1 and SOCS3, known suppres-
sors of tyrosine phosphorylation of STAT-1 (Ito et al, 1999).
Therefore, we used a real-time polymerase chain reaction approach
and quanti¢ed SOCS1, SOCS2, and SOCS3 mRNA expression
in HaCaT cells after UVBR. Indeed SOCS1, and SOCS3
but not SOCS2 were potently induced by UVB (Fig 6).
An approximately 2- to 8-fold induction was found with a
fast peak (after 0.5 h and 1 h, respectively) and subsequent
decrease.
UVBR induces cutaneous SOCS1 and SOCS3 expression
To determine the in vivo relevance of our ¢ndings we measured
gene expression in biopsies from the same psoriatic plaques
obtained before and after UVB radiation. As shown in Table II
an almost 2-fold increase of SOCS1 and SOCS3 was found,
whereas SOCS2 expression was unchanged. These data are
therefore in line with the results from the in vitro investigations.
DISCUSSION
Our results corroborate previously published work indicating
that UVBR inhibits the IFN-g-induced keratinocyte activation
temporarily and that this is probably mediated via the inhibition
of STAT-1 phosphorylation. By analyzing the underlying, more
Figure 3. UVB inhibits the IFN-c-induced STAT-1 phosphoryla-
tion. HaCaT cells were cultured for 48 h. UVBRwas performed at 150 J
per m2, followed by IFN-g stimulation (10 ng per mL) with recombinant
human IFN-g 4 h after irradiation. Fifteen minutes after treatment, HaCaT
cells were harvested by trypsination. Protein extracts were prepared by so-
lubilizing cells in lysis bu¡er.Western blot analysis was performed using
anti-phosphotyrosine STAT-1 (A-2, Santa Cruz Biotechnology, no. J120)
and whole cell extracts: lane 1, control; lane 2, IFN-g stimulation; lanes 3
and 4, UVBRþ IFN-g stimulation; lane 5, UVBR.
Figure 4. Neither IL-10 neutralization nor IL-10 addition had any
e¡ect on the UV-induced inhibition of IFN-c-induced CD54
expression. Keratinocytes were incubated in the presence of a neutralizing
anti-IL-10 monoclonal antibody at a concentration of 10 mg per mL added
immediately after UV irradiation for 28 h (HaCaT, A), or in the presence of
IL-10 at a concentration of 20 ng per mL (HaCaT, B; fresh keratinocytes, C)
added 4 h after UVR for 24 h. po0.05, po0.005. UVBRþ IFN-g
stimulation anti-IL-10: anti-IL-10 incubation; IL-10: IL-10 incubation.
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detailed mechanisms for these e¡ects we demonstrated that they
are clearly independent of IL-10 and they seem to be even inde-
pendent of any soluble mediator at all. In contrast, we found a
strong upregulation of SOCS1 and SOCS3 molecules by UVB
in HaCaT cells (Fig 6), which may explain the phenomenon.
Our preliminary ¢rst experiments with fresh keratinocytes sug-
gest that UVR induces these molecules in these cells too (data
not shown). Remarkably, we also found the same SOCS induc-
tion pattern when analyzing skin biopsies from patients under-
going UVBR (Table II), supporting the in vivo relevance of our
¢ndings. To the best of our knowledge this is one of the ¢rst re-
ports on the capability of UV light to induce members of this
newly discovered family of important intracellular regulators of
immunoactivation. It has been recently described that UVR also
inhibits IL-2-induced phosphorylation of STAT-5 (Kulms and
Schwarz, 2001). This observation might support our conclusion
of SOCS induction by UVR as a mechanism to achieve IFN-g
unresponsiveness.
It is important to study the immunomodulatory e¡ects of
UVR. On the one hand an association between immunosuppres-
sion and the development of primary skin cancers has been de-
monstrated (Fischer and Kripke, 1982; Ullrich, 2002). Therefore,
insight into the mechanisms by which UV suppresses immune
responses may help in providing new approaches for the treat-
ment and prevention of skin cancer (Ullrich, 2002). On the other
hand, a profound understanding of the mode of action of UV
phototherapy may also lead to new approaches for the treatment
of in£ammatory skin diseases.
Despite the major progress in analyzing cellular and molecular
e¡ects of UVR/phototherapy achieved over the last few decades,
the mechanisms have still not been elucidated completely. Ara-
gane and coworkers demonstrated for the ¢rst time that UVR
inhibits IFN-g signaling by blocking phosphorylation of STAT-
1, and suspected that that activation of a phosphatase might be
involved in this process (Aragane et al, 1997). The direct induction
of SOCS molecules by UV light reported here probably contri-
butes to the immunomodulatory e¡ects of UV phototherapy and
therefore should contribute to a further understanding of this
successful therapy. This is supported by the known anti-in£am-
matory/immunosuppressive properties of SOCS molecules in
general on the one hand (Chen et al, 2000) and a recent report
describing impaired IFN-g-dependent in£ammatory responses
in human keratinocyte transfected with SOCS1 and SOCS3
(Federici et al, 2002) on the other hand. Indeed, it was reported
that SOCS1, and to a lesser extent SOCS3, reduced membrane
expression of ICAM-1 and HLA-DR in keratinocyte clones pro-
moted by IFN-g. Moreover, very recently Yamasaki et al (2003)
nicely demonstrated that fresh keratinocytes express SOCS1 and
SOCS3 after IFN stimulation and that transfection of keratino-
cytes with SOCS1 and to a lesser extent SOCS3 inhibited the
IFN-g-induced STAT-1 phosphorylation in keratinocytes, de-
monstrating functional relevance of these molecules. Remark-
ably, we found the very same two molecules were upregulated
by UVBR in vitro and in vivo. Analyzing the kinetics of SOCS
induction in HaCaT cells we observed high levels of mRNA
only 0.5 h after UVR, which ¢ts with the time when the inhibi-
tory e¡ects of UVB on IFN-g-induced keratinocyte activation
are present (after a few hours). Twenty-four hours after UVR,
however, SOCS expression was still higher than before stimulation
Figure 5. A soluble factor is not involved in the UVB-induced inhi-
bition of IFN-c activation of keratinocytes. Supernatants of UV-
radiated keratinocytes were collected after 4 h and replaced by those from
nonradiated cells. Thereafter cells were stimulated with IFN-g (10 ng per
mL) for another 24 h. CD54 (A) and HLA-DR (B) were measured by £ow
cytometric analysis. po0.05, po0.005. IFN-g: IFN-g stimulation; UV:
UVBR; UVþ IFN-g: UVBRþ IFN-gþ Sþ IFN-g: supernatant of UV-
radiated cells, stimulation IFN-g; UV-Sþ IFN-g: UV-radiated cells with-
out their supernatant, stimulated with IFN-g.
Figure 6. UVB induces SOCS expression in keratinocytes. HaCaT
cells were incubated after UVB radiation (150 J per m2) for up to 48 h.
Cellular cDNA was generated as described under Materials and Methods.
Real-time reverse transcription^polymerase chain reaction was performed
to determine the expression levels of SOCS1, SOCS2, and SOCS3
mRNA. The stimulated SOCS expression is shown as expression relative
to the basal levels (fold induction). Data from the mean of three
experiments.
Table II. E¡ects of UVBR on cutaneous SOCS expression
Patient 1 Patient 2
Before UVBR After UVBR Before UVBR After UVBR
SOCS1 0.323 0.612 0.304 0.489
SOCS2 0.112 0.093 0.115 0.118
SOCS3 0.437 0.721 0.386 0.521
Skin biopsies were obtained from lesional psoriatic skin in patients before and
after UVB radiation and cDNAwas generated as well as the real time reverse tran-
scription^polymerase chain reaction performed as described under Materials and
Methods. The data are the expression values relative to the house- keeping gene
HPRT.
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suggesting that other mechanisms are involved in the late stimu-
latory e¡ects of UVR.Whereas it has been demonstrated that IL-
10 is a typical inducer of SOCS3 (Cassatella et al, 1999) our data
show that IL-10 fails to mediate this important e¡ect in keratino-
cytes (Seifert et al, 2003).
Our data may also contribute to a further understanding of the
role of IL-10 in keratinocyte biology.The vast majority of reports
describes that human keratinocytes do produce IL-10 like their
murine counterparts (Enk and Katz, 1992; Kang et al, 1994; Enk
et al, 1995; Grewe et al, 1995), whereas this was challenged by an-
other report (Teunissen et al, 1997).Whereas the e¡ects of IL-10
on several epithelial cell types are well established, the capability
of IL-10 to target keratinocytes is still a matter of debate (Seifert
et al, 2003). Cutaneous IL-10 expression, however, is clearly upre-
gulated by UVR and its secretion is suggested to limit cutaneous
in£ammation (Enk et al, 1995) and to lead to systemic immuno-
suppressive e¡ects. Considering that it has also been demonstra-
ted that IL-10 is a potent inhibitor of STAT-1 phosphorylation we
postulated that UV-induced IL-10 might be responsible for the
IFN-g unresponsiveness of keratinocytes. Our experiments re-
ported here, however, fairly clearly exclude any role of IL-10 in
this context. Based on more recent data our ¢ndings are not that
surprising. Previous observations demonstrated no e¡ect of IL-10
on keratinocyte proliferation, surface molecule expression, and
cytokine secretion (Seifert et al, 2000; Chatelain et al, 1998). De-
scribed that IL-10 inhibits ICAM-1 expression on Langerhans
cells but not on keratinocytes. Finally, very recently we demon-
strated that IL-10 is neither able to induce its typical early gene
products SOCS1 and SOCS3 nor to modulate the IFN-g-induced
expression of SOCS1 and SOCS3 in keratinocytes. Moreover, we
excluded speci¢c binding to primary keratinocytes and HaCaT
cells and demonstrated that the absence of any speci¢c binding
results from the lack of IL-10R1 (a chain) expression (Seifert et
al, 2003). In conclusion it can now be more generally stated that
IL-10 seems not to have any signi¢cant direct e¡ect on keratino-
cytes, including following UVR. Clinical e⁄cacy of IL-10 has
been demonstrated in psoriasis. Response to therapy is associated
with normalization of typical parameters of keratinocyte pathol-
ogy (Asadullah et al, 2001). It can now be concluded that any IL-
10 e¡ects on keratinocytes observed during this therapy are indir-
ectly mediated. This is also supported by the pharmacokinetic
pro¢le of IL-10 after injection (Huhn et al, 1996), suggesting a dis-
tribution mainly restricted to the circulation. Thus, potential pri-
mary target cells of IL-10 are primary and in particular secondary
cutaneous immune cells (after migration from the blood into the
skin), such as lymphocytes, monocytes, and other antigen-pre-
senting cells, which have been shown to be highly sensitive to
IL-10 (Moore et al, 2001).
If immunosuppressive e¡ects of UV phototherapy are indeed
mediated via regulation of SOCS expression, these molecules
themselves might represent interesting new drug targets.Whereas
induction of certain SOCS molecules could be a novel approach
for the limitation of unwanted e¡ects of certain cytokines (cur-
rently achieved by neutralizing antibodies or soluble receptors,
e.g., anti-tumor necrosis factor strategies), inhibition of certain
SOCS molecules might be bene¢cial in diseases where e¡ects of
certain cytokines (e.g., IL-10 as an anti-in£ammatory principle,
IFN-b as an immunomodulatory principle, and IFN-a and
IFN-g as immunostimulatory principles) are desired. In both
cases modulation of the e¡ect of the endogenous expressed cyto-
kines might be su⁄cient or could be considered as an additional
approach, adjuvant to the application of the cytokine or its inhi-
bitor. Thus, further investigations of the e¡ects of UV light on
SOCS expression would be highly desirable. Apart from exten-
sive dose^e¡ect relations in keratinocytes and other cell popula-
tions and further kinetic analyses it would be important to
determine whether the UVB induction of SOCS molecules that
we demonstrated on the gene expression level, is also re£ected on
the protein level. Moreover, an essential role of SOCS induction
on UVB-induced IFN-g unresponsiveness has to be proven in
further investigations. So the concrete functional relevance of
SOCS induction for the UV-induced IFN-g unresponsiveness
needs to be demonstrated. Such experiments may include cellular
gene block experiments by anti-sense techniques (Barkai et al,
2000) and investigations using knock-out mice. These experi-
ments, however, are quite challenging (e.g., due to very early
mortality of several SOCS knock-out mice).
The authors wish to thank Brigitte Ketel and Annette Bu for excellent technical help,
Sandra Phillip for providing the skin biopsies, and Mary Murphy for editing the
manuscript.
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